Pen Needles Market
Pen Needles
Market To Reach
USD 2.48 Billion
By 2026
Markett Summary
Increasing elderly populations, rising incidence of obese-related diabetes, and a favorable
reimbursement scenario are the key factors leading to the burgeoning growth in demand.
Market Size – USD 1.43 Billion in 2018, Market Growth - CAGR of 7.3%, Market Trends –
Growing incidence of diabetes.
The global pen needles market is forecast to reach USD 2.48 Billion by 2026, according to a new
report by Reports and Data. Pen needles are used for the drug administration for many diseases
and are used by both healthcare professionals and patients themselves. They have become
popularly accepted with the advancements in therapy and a supportive reimbursement
structure in many nations.
According to the World Health Organization (WHO), from 2015 to 2050, the aged population
across the globe will be rise from 12% to 22% of the total global population. Owing to this, the
incidence of target diseases such as chronic diseases and cancer is expected to grow and, in
return, will boost the demand. An increase in healthcare expenditure across the globe also
supports the adoption of user-friendly technologies. According to the American Diabetes
Association, the annual healthcare cost in the U.S. increased by 26% during the last five years
due to increased diabetes incidences.
www.reportsanddata.com
Further key findings from the report suggest
• 4mm pen needles provide equal glycaemic control when compared to longer needles. 4mm
pen needles have been shown to cause less pain as compared to longer needles, reduce any
anxiety associated with injection, and provide an overall improved experience, which helps
people with diabetes adhere more to an insulin injectable therapy program and also
improves outcomes.
• Retailer segment is primarily driven by consumers falling under the developing regions
cohort. The rising cases of diabetes is a major driving factor for the manufacturers.
Companies can tap into these unique market characteristics by building a robust
distribution system based on retail sales.
• The standard pen needles are used by the healthcare professionals as well as individual
patients for injecting a variety of medications into the body. These pens are most commonly
used by people with diabetes who often require multiple dosage of insulin injections daily.
Markett Summary
Key Players:
Becton, Dickinson and Co., B. Braun Melsungen AG, HTL-STREFA S.A., Terumo Corporation, Owen Mumford,
Novo Nordisk A/S, Ypsomed Holding AG, Allinson Medical, Inc., Artsana S.p.a
Segmentation:
For the purpose of this study, Reports and Data have segmented the Pen Needles market on the basis of type, length,
therapy, mode of purchase, and region:
Type (Revenue, USD Million; 2016–2026)
• Standard Pen Needles
• Safety Pen Needles
Length (Revenue, USD Million; 2016–2026)
• 4 mm
• 5 mm
• 6 mm
• 8 mm
• 10 mm
• 12 mm
To look at the PDF Sample Report and get 30 minutes of a free consultation @ https://
www.reportsanddata.com/sample-enquiry-form/2124
www.reportsanddata.com
Markett Summary
Therapy (Revenue, USD Million; 2016–2026)
• Insulin Therapy
• Glucagon-Like Peptide-1 ((glp-1) Therapy
• Growth Hormone Therapy
• Others
Mode of Purchase (Revenue, USD Million; 2016–2026)
• Retail
• Non-Retail
Regional Outlook (Revenue in USD Million; 2016–2026)
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America
Grab Your Report at an Impressive Discount! Please Click Here : https://
www.reportsanddata.com/make-enquiry-form/2124
www.reportsanddata.com
The reportt emphasiizes tthe ffollllowiing key questtiions::
Q.1.What are the most lucrative and promising growth prospects for the market?
Q.2.Which sectors are expected to deliver a high growth rate and which industry aspects
come into play in this advancement?
Q.3.Which geographies are estimated to exhibit the highest growth and the underlying
causes?
Q.4.Which factors are impacting the future of the market and what are the driving
factors?
Q.5.What are the hurdles and challenges curtailing the industry’s growth in the forecast
period?
www.reportsanddata.com
About Us
Reports and Data is a market research and consulting company that provides
syndicated research reports, customized research reports, and consulting services.
Our solutions purely focus on your purpose to locate, target and analyze consumer
behavior shifts across demographics, across industries and help client’s make a
smarter business decision. We offer market intelligence studies ensuring relevant
and fact-based research across a multiple industries including Healthcare,
Technology, Chemicals, Power, and Energy. We consistently update our research
offerings to ensure our clients are aware about the latest trends existent in the
market. Reports and Data has a strong base of experienced analysts from varied
areas of expertise.
Contact Us:
John Watson
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
Comments